PROSTATE CANCER ASSOCIATED HUMAN FIBRONECTIN GENE AND BIALLELIC MARKERS
The invention concerns the genomic sequence of the Fibronectin gene. The invention also concerns biallelic markers of a Fibronectin gene and the association established between these markers and cancer, particularly prostate cancer. The invention provides means to determine the predisposition of individuals to cancer as well as means for the diagnosis of cancer and for the prognosis/detection of an eventual treatment response to agents acting on cancer.